Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colet

Showing results (601-610 of 608) with videos related to

Pageof 61
Sort By:
You have reached the last page of results.This site can display upto 608 results.
International Journal of Cardiology|June 3, 2017
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapyGerhard Pölzl, Johann Altenberger, Loant Baholli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 9, 2020
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illnessManuel Rubio-Rivas, Mar Ronda, Ariadna Padulles, et al.
Journal of Cardiovascular Pharmacology|July 9, 2020
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.
The New England Journal of Medicine|August 26, 2022
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D Solomon, John J V McMurray, Brian Claggett, et al.
Cardiac Failure Review|July 28, 2020
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.
European Journal of Heart Failure|May 11, 2024
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialScott D Solomon, John W Ostrominski, Muthiah Vaduganathan, et al.
The New England Journal of Medicine|September 3, 2024
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D Solomon, John J V McMurray, Muthiah Vaduganathan, et al.
Circulation. Heart Failure|July 8, 2018
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF TrialScott D Solomon, Adel R Rizkala, Martin P Lefkowitz, et al.
Pageof 61

Showing results (601-610 of 608) with videos related to

Sort By:
Pageof 61
You have reached the last page of results.This site can display upto 608 results.
International Journal of Cardiology|June 3, 2017
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapyGerhard Pölzl, Johann Altenberger, Loant Baholli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 9, 2020
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illnessManuel Rubio-Rivas, Mar Ronda, Ariadna Padulles, et al.
Journal of Cardiovascular Pharmacology|July 9, 2020
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.
The New England Journal of Medicine|August 26, 2022
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D Solomon, John J V McMurray, Brian Claggett, et al.
Cardiac Failure Review|July 28, 2020
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.
European Journal of Heart Failure|May 11, 2024
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialScott D Solomon, John W Ostrominski, Muthiah Vaduganathan, et al.
The New England Journal of Medicine|September 3, 2024
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D Solomon, John J V McMurray, Muthiah Vaduganathan, et al.
Circulation. Heart Failure|July 8, 2018
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF TrialScott D Solomon, Adel R Rizkala, Martin P Lefkowitz, et al.
Pageof 61